On Tuesday, Heron Therapeutics Inc (NASDAQ: HRTX) opened lower -3.39% from the last session, before settling in for the closing price of $1.18. Price fluctuations for HRTX have ranged from $1.04 to $2.68 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 48.68%. Company’s average yearly earnings per share was noted -11.11% at the time writing. With a float of $181.93 million, this company’s outstanding shares have now reached $183.31 million.
The extent of productivity of a business whose workforce counts for 122 workers is very important to gauge.
Heron Therapeutics Inc (HRTX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Heron Therapeutics Inc is 0.76%, while institutional ownership is 73.93%. The most recent insider transaction that took place on Aug 08 ’25, was worth 3,580,838. In this transaction 10% Owner of this company bought 2,387,225 shares at a rate of $1.50, taking the stock ownership to the 29,100,728 shares. Before that another transaction happened on Aug 08 ’25, when Company’s Director bought 1,766,546 for $1.50, making the entire transaction worth $2,649,819. This insider now owns 8,753,290 shares in total.
Heron Therapeutics Inc (HRTX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.02 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.03) by 0.05.
According to the Wall Street analysts, stocks earnings will be around -11.11% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Check out the current performance indicators for Heron Therapeutics Inc (HRTX). In the past quarter, the stock posted a quick ratio of 0.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.01, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.00 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
The latest stats from [Heron Therapeutics Inc, HRTX] show that its last 5-days average volume of 3.17 million was superior to 1.69 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.78%.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 5.69%, which indicates a significant decrease from 22.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0811 in the past 14 days, which was lower than the 0.0839 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2716, while its 200-day Moving Average is $1.7917. Now, the first resistance to watch is $1.1967. This is followed by the second major resistance level at $1.2533. The third major resistance level sits at $1.3167. If the price goes on to break the first support level at $1.0767, it is likely to go to the next support level at $1.0133. Assuming the price breaks the second support level, the third support level stands at $0.9567.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
There are currently 183,314K shares outstanding in the company with a market cap of 208.98 million. Presently, the company’s annual sales total 144,290 K according to its annual income of -13,580 K. Last quarter, the company’s sales amounted to 37,200 K and its income totaled -2,380 K.
